STOCK TITAN

Praxis (NASDAQ: PRAX) director William Young receives RSU and option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Praxis Precision Medicines director William D. Young received new equity awards. On June 10, 2026, he was granted 1,371 restricted stock units, each representing one future share of common stock, vesting in a single installment on the earlier of June 10, 2027 or the 2027 annual stockholders meeting.

He was also granted a stock option for 648 shares of common stock at an exercise price of $240.6600 per share, vesting in twelve equal monthly installments beginning July 10, 2026 through the earlier of June 10, 2027 or the 2027 annual meeting. Following these awards, he directly owns 3,269 common shares and holds options for 648 shares.

Positive

  • None.

Negative

  • None.
Insider YOUNG WILLIAM D
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 648 $0.00 --
Grant/Award Common Stock 1,371 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 648 shares (Direct, null); Common Stock — 3,269 shares (Direct, null)
Footnotes (1)
  1. Mr. Young was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
Restricted stock units granted 1,371 units RSU grant to director on June 10, 2026
RSU vesting date June 10, 2027 Single installment or earlier 2027 annual meeting
Stock options granted 648 options Option grant to purchase common stock
Option exercise price $240.6600 per share Strike price for 648-share option grant
Option vesting period start July 10, 2026 First of twelve monthly vesting installments
Option expiration date June 10, 2036 Expiration of stock option if unexercised
Shares held after grant 3,269 shares Common stock directly owned post-award
Options held after grant 648 options Derivative position following transaction
restricted stock units financial
"Mr. Young was awarded 1,371 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
stock option financial
"The shares subject to this option shall vest in twelve (12) equal monthly installments"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"shall vest in twelve (12) equal monthly installments occurring on the 10th day"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"the Issuer's 2027 annual meeting of stockholders"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YOUNG WILLIAM D

(Last)(First)(Middle)
C/O PRAXIS PRECISION MEDICINES, INC.
99 HIGH STREET, 30TH FLOOR

(Street)
BOSTON MASSACHUSETTS 02110

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Praxis Precision Medicines, Inc. [ PRAX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026A(1)1,371A$03,269D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$240.6606/10/2026A648 (2)06/10/2036Common Stock648$0648D
Explanation of Responses:
1. Mr. Young was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
Remarks:
/s/ Alex Nemiroff, as Attorney-in-Fact06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did PRAX director William D. Young receive?

William D. Young received 1,371 restricted stock units and a stock option for 648 shares of Praxis Precision Medicines common stock. These are compensation-related grants, not open-market purchases or sales, and provide future rights to company shares subject to vesting.

How do the 1,371 PRAX restricted stock units for William Young vest?

The 1,371 restricted stock units vest in a single annual installment on the earlier of June 10, 2027 or Praxis Precision Medicines’ 2027 annual meeting of stockholders. Each unit converts into one share of common stock and can only be settled in shares.

What are the key terms of William Young’s 648-share PRAX stock option?

William Young’s stock option covers 648 shares of Praxis common stock at an exercise price of $240.6600 per share. It vests in twelve equal monthly installments starting July 10, 2026 and expires on June 10, 2036, if not exercised earlier.

When will William Young’s PRAX stock option be fully vested?

The 648-share stock option vests in twelve equal monthly installments beginning July 10, 2026. The final installment vests on the earlier of June 10, 2027 or Praxis Precision Medicines’ 2027 annual meeting of stockholders, assuming continued service under the award terms.

How many PRAX common shares does William Young hold after these grants?

After the June 10, 2026 awards, William Young directly owns 3,269 shares of Praxis common stock. In addition, he holds a stock option for 648 shares, which represents a right to purchase additional shares at the specified exercise price.